LINEAGE THERAP earnings per share and revenue

LCTX earnings per share for the last quarter are -0.11 ILS whereas the estimation was -0.16 ILS which accounts for 30.00% surprise. Company revenue for the same period amounts to 7.62 M ILS despite the estimated figure of 9.60 M ILS. Estimated earnings per share for the next quarter are -0.14 ILS, and revenue is expected to reach 5.03 M ILS. Also watch annual changes over time to get a bigger picture of LCTX earnings per share and revenue dynamics.